Skip to Content
Translational Research Program (TRP)
Last Updated: 09/22/16

Breast SPOREs

Breast cancer is one of the most common forms of cancer diagnosed in women in the United States and is second only to lung cancer in cancer deaths. As estimated by the NCI Surveillance, Epidemiology and End Results Program (SEER), approximately 246,660 new invasive breast cancer cases will be identified in women in 2016 and about 40,450 deaths will be attributed to this disease. During the course of her lifetime, a woman has a one in eight chance of developing breast cancer. Much progress has been made over the past decade in identifying hereditary factors, as well as novel therapeutic and preventative agents for breast cancer. The Breast Cancer SPORE program has evolved significantly from 1992, when four sites were funded. Current grants support development of novel therapies and therapeutic approaches (small molecule inhibitors, anti-estrogens, vaccines and antibodies), technologies (microarrays, genomic sequencing and expression profiling, quantitative proteomics, and mass spectrometry), population studies and markers (i.e. cancer-related genes/proteins) that aims to provide a better understanding of tumor resistance; diagnosis, prognosis, screening, prevention, and treatment of breast cancer.

Baylor College of Medicine

C. Kent Osborne, MD [Click Here]
Baylor College of Medicine
One Baylor Plaza, BCM 600
Houston, TX 77030
Tel: (713) 798-1600
Fax: (713) 798-1642
Email: kosborne@bcm.edu

For more information on this specific SPORE’s institution, please visit:
https://www.bcm.edu/centers/breast-center/research/spore

Dana-Farber Harvard Cancer Institute

Eric Winer, MD [Click Here]
Dana-Farber Cancer Institute
Department of Medical Oncology
Division of Women’s Cancers
450 Brookline Avenue, Boston, MA 02215
Tel: (617) 632-2261
Fax: (617) 632-1930
Email: ewiner@partners.org

For more information on this specific SPORE?s institution, please visit:
http://dfhcc.harvard.edu/spores/breast/

Fred Hutchinson Cancer Research Center

Peggy Porter, MD [Click Here]
Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North
PO Box 19024, C1-015
Seattle, WA 98109-1024
Tel: (206) 667-3751
Fax: (206) 667-7264
Email: pporter@fhcrc.org

For more information on this specific SPORE’s institution, please visit:
http://www.fhcrc.org/en/labs/science-projects/breast-cancer-program/seattle-cancer-consortium-breast-spore.html

Mayo Clinic, Rochester

Matthew P. Goetz, M.D. [Click Here]
Professor of Oncology
Associate Professor of Pharmacology
Chair, Mayo Breast Cancer Research Disease Orientated Group
Co-Leader, Women’s Cancer Program
Consultant, Medical Oncology
Mayo Clinic College of Medicine
200 First St. S.W.
Rochester, MN 55905
Tel: 507-284-4857
Fax: 507-284-1803
Email: goetz.matthew@mayo.edu

James N. Ingle, M.D.
Co-Director, Women’s Cancer Program
Mayo Clinic and Foundation
Department of Oncology
Mayo Clinic College of Medicine
200 First Street Southwest
Rochester, MN 55905
Tel: (507) 284-8432
Fax: (507) 538-0823
Email: ingle.james@mayo.edu

For more information on this specific SPORE’s institution, please visit:
http://cancercenter.mayo.edu/mayo/research/womens_cancer/spore_grant.cfm

University of North Carolina at Chapel Hill

H. Shelton Earp, III, MD [Click Here]
University of North Carolina at Chapel Hill
Department of Medicine
Campus Box 7295, Rm. 10-012
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
Tel: (919) 966-2335
Fax: (919) 966-3015
Email: hse@med.unc.edu

Charles M. Perou, PhD
Professor of Genetics, and Pathology & Laboratory Medicine
Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Campus Box 7295
Chapel Hill, NC 27599
Tel: 919-843-5740
Fax: 919-843-5718
Email: cperou@med.unc.edu

For more information on this specific SPORE’s institution, please visit:
https://unclineberger.org/research/research-programs/breast-cancer/spore

Vanderbilt University

Carlos Arteaga, MD [Click Here]
Vanderbilt University Medical Center
Vanderbilt-Ingram University Cancer Center
Department of Medicine
2200 Pierce Avenue
777 Preston Research Building
Nashville, TN 37232
Tel: (615) 936-3524
Fax: (615) 936-1790
Email: carlos.arteaga@vanderbilt.edu

For more information on this specific SPORE’s institution, please visit:
http://www.vicc.org/spores/breast/